Subcutaneous terbutaline and control of brittle asthma or appreciable morning dipping. Issue 6432 (9th June 1984)

• Record Type: Journal Article
• Authors: Ayres, J; Fish, D R; Wheeler, D C; Wiggins, J; Cochrane, G M; Skinner, C
• Is Part Of: BMJ. Volume 288:Issue 6432(1984)
• Page Start: 1715
• Page End: 1716
• Publication Date: 1984-06-09
• Subjects: Medicine -- Periodicals; Medicine -- Periodicals; Medicine; Periodicals; 610
• DOI: 10.1136/bmj.288.6432.1715
• Languages: English
• ISSNs: 0007-1447

Abstract

Abstract : In a pilot study two patients with brittle asthma and two with morning dipping received terbutaline or a placebo administered subcutaneously either by continuous infusion or in injections every six hours. In two patients brittle asthma was completely suppressed by terbutaline 1 mg/day given by either method. In the two others early morning dipping responded only to continuous subcutaneous infusions of terbutaline 12 mg/day. Terbutaline administered subcutaneously may be an effective treatment in asthmatic patients who show important diurnal variations in air flow.